| DIA | SPHD | DIA / SPHD | |
| Gain YTD | 8.790 | 8.183 | 107% |
| Net Assets | 44.8B | 3.34B | 1,341% |
| Total Expense Ratio | 0.16 | 0.30 | 53% |
| Turnover | 8.00 | 49.00 | 16% |
| Yield | 1.38 | 4.66 | 30% |
| Fund Existence | 29 years | 14 years | - |
| DIA | SPHD | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 90% | 2 days ago 86% |
| Momentum ODDS (%) | 2 days ago 70% | 2 days ago 69% |
| MACD ODDS (%) | 2 days ago 70% | 2 days ago 67% |
| TrendWeek ODDS (%) | 2 days ago 74% | 2 days ago 71% |
| TrendMonth ODDS (%) | 2 days ago 74% | 2 days ago 73% |
| Advances ODDS (%) | 16 days ago 85% | 5 days ago 84% |
| Declines ODDS (%) | 3 days ago 76% | 3 days ago 73% |
| BollingerBands ODDS (%) | 2 days ago 85% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 76% | 2 days ago 70% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SMCZ | 5.16 | 0.27 | +5.52% |
| Defiance Daily Target 2X Short SMCI ETF (SMCZ) | |||
| QVML | 45.35 | 0.09 | +0.20% |
| Invesco S&P 500 QVM Multi-factor ETF (QVML) | |||
| HELX | 43.15 | N/A | N/A |
| Franklin Genomic Advancements ETF (HELX) | |||
| ZTR | 6.30 | -0.04 | -0.63% |
| Virtus Total Return Fund | |||
| IDYN | 30.66 | -0.31 | -1.00% |
| iShares International Equity Factor Rotation Active ETF (IDYN) | |||